|
|
Volumn 416, Issue 6882, 2002, Pages 672-674
|
|
Break-bone fever
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DISEASES;
HEALTH RISKS;
TROPICS;
VIRUSES;
BREAK-BONE FEVER;
BIOMEDICAL ENGINEERING;
ANTIBODY;
COAT PROTEIN;
CYTOKINE;
DENGUE VACCINE;
DNA;
DNA VACCINE;
INSECTICIDE;
VIRUS VACCINE;
YELLOW FEVER VACCINE;
DENGUE FEVER;
AEDES AEGYPTI;
ANTIBODY RESPONSE;
CLINICAL TRIAL;
DENGUE;
DENGUE VIRUS;
DNA FINGERPRINTING;
DRUG EFFICACY;
DRUG SAFETY;
EPIDEMIC;
HUMAN;
IMMUNE SYSTEM;
MACROPHAGE;
NONHUMAN;
PRIORITY JOURNAL;
SEROTYPE;
SHORT SURVEY;
VIRULENCE;
VIRUS TRANSMISSION;
ANIMAL;
ARTICLE;
CHILD;
DISEASE CARRIER;
ECONOMICS;
GENETICS;
PHYSIOLOGY;
VIROLOGY;
ANIMALS;
CHILD;
DENGUE;
DENGUE HEMORRHAGIC FEVER;
DENGUE VIRUS;
HUMANS;
INSECT VECTORS;
VIRAL VACCINES;
YELLOW FEVER VACCINE;
|
|
EID: 0037129224
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/416672a Document Type: Short Survey |
|
Times cited : (46)
|
|
References (17)
|
